Business Insider
My Markets Watchlist
Markets Stocks

Sanofi S.A. (spons. ADRs) Stock , SNY

49.99 +0.31 +0.62%
10:53:11 AM BTT
News Analyst Data Analyst Opinions Insider Activity Dividend Calendar

On Monday morning 06/16/2025 the Sanofi S.A. (spons. ADRs) share started trading at the price of $50.03. Compared to the closing price on Friday 06/13/2025 on BTT of $49.68, this is a gain of 0.70%.

Sanofi Stock Snapshot

49.96
Bid
150.00
Bid Size
50.00
Ask
104.00
Ask Size
6/16/2025
Date
10:53 AM
Time
23,852.00
Volume
49.68
Prev. Close
50.03
Open
2.44 B
Number of Shares
2.44 B
Total Number of Shares
49.84
Day Low
50.17
Day High
49.99
45.83
52 Week Low
60.11
52 Week High
49.99
1.60
Dividend in USD
3.31
Dividend Yield
20.07
P/E Ratio
99.98
Free Float in %
2.40
EPS in USD
32.01
Book Value per Share in USD
3.91
Cash Flow per Share in USD

Historical Prices for Sanofi

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

Sanofi Analyst Data

Total Analysts: 3
Buy Ratings: 1 Neutral Ratings: 2 Sell Ratings: 0
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 55.00 Median: 60.00 Highest: 65.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

Sanofi Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
Date Analyst Rating Price
03/21/25 Goldman Sachs
Maintained Hold $65
07/26/24 Argus Research Company
Maintained Buy $60
01/23/24 Morgan Stanley
Maintained Hold $55

Sanofi Estimates* in USD

  2025 2026 2027 2028 2029
Revenue 52,194 55,782 59,116 60,814 64,518
Dividend 2.36 2.48 2.63 2.73 3.07
Dividend Yield (in %) 4.75 % 5.00 % 5.29 % 5.50 % 6.18 %
EPS 4.61 5.03 5.37 5.93 6.54
P/E Ratio 10.77 9.87 9.24 8.37 7.59
EBIT 14,035 15,043 16,045 17,781 19,248
EBITDA 16,311 17,329 18,067 19,922 21,360
Net Profit 11,264 12,132 12,962 14,360 15,853
Net Profit Adjusted 11,264 12,132 12,962 14,360 15,853
Pre-Tax Profit - - - 17,755 19,813
Pre-Tax Profit Reported 9,800 10,926 11,835 14,790 17,861
EPS (Non-GAAP) ex. SOE - - - - -
EPS (GAAP) 3.89 4.19 4.63 5.10 5.80
Gross Income 37,456 40,472 43,249 46,990 50,153
Cash Flow from Investing 6,396 -2,889 -3,062 -3,627 -3,742
Cash Flow from Operations 11,780 13,324 14,408 15,433 16,954
Cash Flow from Financing -13,897 -8,543 -7,517 -8,224 -8,456
Cash Flow per Share 5.13 5.54 6.06 7.04 7.55
Free Cash Flow 10,601 10,086 11,045 11,922 13,360
Free Cash Flow per Share 4.06 4.26 4.64 - 5.45
Book Value per Share 37.15 38.91 41.00 46.31 45.87
Net Debt 6,317 3,186 -1,665 -2,069 -8,445
Research & Development Exp. 8,684 9,104 9,392 9,551 10,028
Capital Expenditure 3,005 3,124 3,248 3,522 3,653
Selling, General & Admin. Exp. 10,686 11,073 11,384 11,630 12,032
Shareholder’s Equity 90,642 94,629 99,759 110,163 112,762
Total Assets 150,883 154,611 159,814 161,071 167,623
  Previous Quarter
ending 03/31/25 		Current Quarter
ending 06/30/25 		Next Quarter
ending 09/30/25 		Current Year
ending 12/31/25 		Next Year
ending 12/31/26
Earnings Estimates
No. of Analysts 9 7 7 21 20
Average Estimate 0.938 USD 0.937 USD 1.733 USD 4.613 USD 5.032 USD
Year Ago - - - 2.403 USD -
Publish Date 4/24/2025 7/31/2025 10/24/2025 - -
Revenue Estimates
No. of Analysts 9 7 7 19 19
Average Estimate 11,277 USD 11,772 USD 15,204 USD 52,194 USD 55,782 USD
Year Ago - - - 44,437 USD -
Publish Date 4/24/2025 7/31/2025 10/24/2025 - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. USD

2024 2023 2022 2021 2020 2019 2018
Sales 44,436.94 46,563.65 45,188.74 44,632.78 41,085.82 40,433.98 40,657.72
Change of sales in % -4.57 3.04 1.25 8.63 1.61 -0.55 2.83
Gross profit on sales 28,117.47 28,647.40 28,525.54 28,147.69 25,177.48 24,462.30 24,468.01
Gross profit on sales change in % -1.85 0.43 1.34 11.80 2.92 -0.02 1.08
Operating income 10,282.55 9,927.88 10,542.32 10,245.41 8,291.03 6,802.79 5,994.31
Operating income change in % 3.57 -5.83 2.90 23.57 21.88 13.49 -11.65
Income before tax 7,245.16 7,733.22 10,953.25 9,217.09 15,736.21 3,158.52 5,196.80
Income before tax change in % -6.31 -29.40 18.84 -41.43 398.21 -39.22 -16.68
Income after tax 5,944.97 5,838.02 8,797.71 7,355.47 14,037.65 3,253.66 5,095.34
Income after tax change in % 1.83 -33.64 19.61 -47.60 331.44 -36.14 19.16

Balance Sheet in Mio. USD

2024 2023 2022 2021 2020 2019 2018
Total liabilities 56,891.41 57,564.42 55,038.08 58,237.15 62,868.45 60,197.43 59,870.19
Long-term liabilities per share 11.53 12.32 11.76 13.58 15.72 14.88 16.06
Equity 80,620.92 82,134.04 80,205.97 78,502.05 77,263.51 66,348.73 67,485.86
Equity change in % -1.87 2.47 2.19 1.32 16.52 -1.71 -3.51
Balance sheet total 137,512.33 139,698.46 135,244.05 136,739.20 140,131.96 126,546.16 127,356.06
Balance sheet total change in % -1.56 3.29 -1.09 -2.42 10.74 -0.64 6.24

Key Data in USD

2024 2023 2022 2021 2020 2019 2018
Sales per share 17.69 18.53 17.98 17.74 16.30 16.08 16.20
P/E ratio (year end quote, basic EPS) 20.07 21.33 13.78 17.06 8.68 38.57 21.25
P/E ratio (year end quote, diluted EPS) 20.15 21.40 13.84 17.14 8.72 38.79 21.39
Dividend yield in % 3.31 2.97 2.84 2.52 2.81 2.34 2.69
Equity ratio in % 58.63 58.79 59.30 57.41 55.14 52.43 52.99
Debt ratio in % 41.37 41.21 40.70 42.59 44.86 47.57 47.01

Sanofi Dividend Calendar

Date Name Dividend *yield Currency
2024 Sanofi S.A. (spons. ADRs) 1.60 3.31 USD
2023 Sanofi S.A. (spons. ADRs) 1.48 2.97 USD
2022 Sanofi S.A. (spons. ADRs) 1.38 2.84 USD
2021 Sanofi S.A. (spons. ADRs) 1.26 2.52 USD
2020 Sanofi S.A. (spons. ADRs) 1.37 2.81 USD
2019 Sanofi S.A. (spons. ADRs) 1.17 2.34 USD
2018 Sanofi S.A. (spons. ADRs) 1.17 2.69 USD
2017 Sanofi S.A. (spons. ADRs) 1.20 2.80 USD
2016 Sanofi S.A. (spons. ADRs) 1.10 2.72 USD
2015 Sanofi S.A. (spons. ADRs) 1.12 2.64 USD
2014 Sanofi S.A. (spons. ADRs) 1.09 2.38 USD
2013 Sanofi S.A. (spons. ADRs) 1.32 2.46 USD
2012 Sanofi S.A. (spons. ADRs) 1.25 2.65 USD
2011 Sanofi S.A. (spons. ADRs) 1.43 3.92 USD
2010 Sanofi S.A. (spons. ADRs) 1.32 4.10 USD
2009 Sanofi S.A. (spons. ADRs) 1.10 2.81 USD
2008 Sanofi S.A. (spons. ADRs) 2.07 - EUR
2007 Sanofi S.A. (spons. ADRs) 1.04 - EUR
2006 Sanofi S.A. (spons. ADRs) 0.76 - EUR
2005 Sanofi S.A. (spons. ADRs) 0.60 - EUR
2004 Sanofi S.A. (spons. ADRs) 0.51 - EUR
2003 Sanofi S.A. (spons. ADRs) 0.42 - EUR
2002 Sanofi S.A. (spons. ADRs) 0.33 - EUR
2001 Sanofi S.A. (spons. ADRs) 0.22 - EUR
*Yield of the Respective Date

Sanofi Calendar

Event Estimate Info Date
Earnings Report 0.937 USD Q2 2025 Earnings Release 07/31/2025
Earnings Report 1.733 USD Q3 2025 Earnings Release 10/24/2025
Earnings Report 0.898 USD Q4 2025 Earnings Release 01/30/2026
Earnings Report 0.984 USD Q1 2026 Earnings Release 04/23/2026
Earnings Report 1.075 USD Q2 2026 Earnings Release 07/23/2026
Earnings Report 1.933 USD Q3 2026 Earnings Release 10/23/2026

Sanofi Past Events

Event Actual EPS Info Date
Annual General Meeting 2.401 USD Annual General Meeting 04/30/2025
Earnings Report - Q2 2024 Earnings Release 07/25/2024
Annual General Meeting 2.330 USD Annual General Meeting 04/30/2024
Earnings Report - Q4 2023 Earnings Release 02/01/2024
Annual General Meeting 3.516 USD Annual General Meeting 05/25/2023
Earnings Report - Q4 2022 Earnings Release 02/03/2023
Earnings Report - Q3 2022 Earnings Release 10/28/2022
Annual General Meeting 2.937 USD Annual General Meeting 05/03/2022
Earnings Report - Q1 2022 Earnings Release 04/28/2022
Earnings Report - Q4 2021 Earnings Release 02/04/2022

Sanofi Profile

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.